(Q51552807)

7 April 2018

title

The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. (English)

1 reference

7 April 2018

author name string

Kahrilas PJ

1

1 reference

7 April 2018

Quigley EM

2

1 reference

7 April 2018

Castell DO

3

1 reference

7 April 2018

Spechler SJ

4

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 November 2000

1 reference

7 April 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

7 April 2018

volume

14

1 reference

7 April 2018

issue

11

1 reference

7 April 2018

page(s)

1503-1509

1 reference

7 April 2018

Epidemiology and natural history of gastro-oesophageal reflux disease

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Anatomy and physiology of the gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Contributing role of motility abnormalities in the pathogenesis of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

A prokinetic approach to treatment of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

The Serotonin 5-HT4 Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Changes in pyloric resistance induced by erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Oesophageal motor responses to gastro-oesophageal reflux in healthy controls and reflux patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00854.X

10.1046/J.1365-2036.2000.00854.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018